Overview

Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis

Status:
Completed
Trial end date:
2021-02-11
Target enrollment:
Participant gender:
Summary
This study evaluates the safety of resiniferatoxin in patients with moderate to severe knee pain due to osteoarthritis.
Phase:
Phase 1
Details
Lead Sponsor:
Sorrento Therapeutics, Inc.